JYNT
The Joint Corp.
JYNT has the edge over UNH overall, supported by stronger valuation and stronger fundamentals.
UNH
UnitedHealth Group Incorporated
UNH's outlook is improving, though it still trails on the overall score.
JYNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
JYNT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
JYNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $6.69 | — |
| Current | 33x | $6.69 | — |
| Cheap | 44x | $8.80 | +32% |
| Fair | 70x | $13.93 | +108% |
| Expensive | 110x | $22.06 | +230% |
Historical ranges are pointers, not guarantees.
JYNT has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
JYNT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect JYNT's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
JYNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +63% |
| Q3 2026 | $0.20 | +54% |
| Q2 2026 | $0.27 | +$0.41 |
| Q1 2026 | $0.23 | +$0.62 |
| Q4 2025 | $0.20 | +$0.59 |
| Q3 2025 | $0.13 | +$1.26 |
| Q2 2025 | -$0.14 | +$0.83 |
| Q1 2025 | -$0.39 | +$0.36 |
| Q4 2024 | -$0.39 | +$0.26 |
JYNT has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
JYNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.6M | +1.3% |
| Q2 2026 | $15.2M | +14% |
| Q1 2026 | $14.8M | +13% |
| Q4 2025 | $15.2M | +3.1% |
| Q3 2025 | $13.4M | -56% |
| Q2 2025 | $13.3M | -56% |
| Q1 2025 | $13.1M | -56% |
| Q4 2024 | $14.7M | -52% |
JYNT's revenue has grown year over year for four quarters in a row: $14M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | +8.6 points |
| Q2 2026 | -2.4% | +6.2 points |
| Q1 2026 | 5.9% | +11 points |
| Q4 2025 | 4.9% | -0.6 points |
| Q3 2025 | 1.2% | +12 points |
| Q2 2025 | -8.6% | +3 points |
| Q1 2025 | -5.2% | -8.9 points |
| Q4 2024 | 5.5% | +6 points |
JYNT has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over JYNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
JYNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$508.6K | -135% |
| Q2 2026 | $1.9M | +432% |
| Q1 2026 | -$1.7M | +$2.3M |
| Q4 2025 | $2.5M | -34% |
| Q3 2025 | $1.5M | -55% |
| Q2 2025 | $363.6K | +$1.6M |
| Q1 2025 | -$4M | -267% |
| Q4 2024 | $3.8M | +73% |
JYNT usually generates cash, though not every quarter: the latest was −$508,635, but it generated $2M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over JYNT on cash flow, with more consistent year-over-year improvement.
JYNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -215K shares |
| 1 year | -8.9% | -1.4M shares |
| 3 years | -6.6% | -984K shares |
| 5 years | -6.3% | -938K shares |
| Available history | -3% | -436K shares |
JYNT has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.8M |
| Q2 2026 | $676,810 |
| Q1 2026 | $1.1M |
| Q4 2025 | $9M |
| Q3 2025 | $2.3M |
| Q2 2025 | — |
| Q1 2025 | $8,440 |
| Q4 2024 | — |
JYNT spent $15M buying back its own shares over the past year, about six times what it spent the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
JYNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.5x | Net Cash |
| Q2 2026 | -7.1x | Net Cash |
| Q1 2026 | -8.9x | Net Cash |
| Q4 2025 | -31.2x | Net Cash |
| Q3 2025 | -39.9x | Net Cash |
| Q3 2024 | -180.9x | Net Cash |
| Q2 2024 | -5.0x | Net Cash |
| Q1 2024 | -2.5x | Net Cash |
JYNT has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
JYNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 9.3 | Oversold |
JYNT's weekly RSI is 32 (neutral) and its Stochastic is 9 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
JYNT PE vs Healthcare Sector
| Metric | JYNT | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 26x | 29% above |
| PE % | 5 | 29 | 24 pts below |
JYNT is trading at 33x earnings, a 29% premium to the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over JYNT on valuation relative to its sector.
JYNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.17 | 6.7% below |
| 20 week MA | $7.96 | 16% below |
| 50 week MA | $8.54 | 22% below |
| 100 week MA | $9.49 | 30% below |
| 200 week MA | $10.9 | 39% below |
JYNT is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over JYNT on trend strength, trading above more of its moving averages.
JYNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.3 | $25.5 | +57% |
| 2021 | $25.5 | $64.7 | +153% |
| 2022 | $64.7 | $15.1 | -77% |
| 2023 | $15.1 | $9.61 | -36% |
| 2024 | $9.61 | $9.90 | +3% |
| 2025 | $9.90 | $8.76 | -12% |
| 2026 YTD | $8.76 | $6.69 | -24% |
JYNT's yearly returns have swung widely, from +153% in 2021 to −77% in 2022. It's down 24% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over JYNT on returns for 2026, with the stronger performance.